Vnitr Lek 2023, 69(3):E16-E19 | DOI: 10.36290/vnl.2023.036

Barakat syndrome

Beáta Arciniegas Berkešová1, 2, Zoltán Borbély2, 3
1 Endokrinologická ambulancia Kliniky vnútorného lekárstva II, FNsP Nové Zámky
2 Klinika vnútorného lekárstva II, FNsP Nové Zámky
3 Nefrologická ambulancia Kliniky vnútorného lekárstva II, FNsP Nové Zámky

Barakat syndrome, also known as HDR syndrome, is a clinically heterogenous, autosomal dominant rare genetic disease, which frequency is unknown. It is primarily caused by deletion of chromosome 10p14 or mutation of GATA3 gene, located on chromosome 10. Although this syndrome is phenotypically defined by its triad of HDR: hypoparathyroidism (H), deafness (D), renal disease (R), the literature identifies cases with different components, consisting of HD, DR, HR (1). The syndrome was first described by Amin J. Barakat et al. in 1977 in siblings with hypocalcemia and proteinuria (2). So far, about 180 cases have been reported in the worldwide medical literature (3). In this report we present our own case report of patient with Barakat syndrome with hypoparathyrodism, unilateral deafness and renal impairment.

Keywords: Barakat syndrome, deafness, GATA3, HDR syndrome, hypocalcemia, hypoparathyroidism, chromosome 10p, renal disease.

Accepted: April 27, 2023; Published: May 16, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Arciniegas Berkešová B, Borbély Z. Barakat syndrome. Vnitr Lek. 2023;69(3):E16-19. doi: 10.36290/vnl.2023.036.
Download citation

References

  1. Barakat AJ, Raygada M, Rennert OM. Barakat syndrome revisited. Am J Med Genet A. 2018 Jun;176(6):1341-1348. doi: 10.1002/ajmg.a.38693. Epub 2018 Apr 16. PMID: 29663634. Go to original source... Go to PubMed...
  2. Barakat AJ, D'Albora JB, Martin MM, Jose PA. Familial nephrosis, nerve deafness, and hypoparathyroidism. J Pediatr. 1977 Jul;91(1):61-4. doi: 10.1016/s0022-3476(77)80445-9. PMID: 874665. Go to original source... Go to PubMed...
  3. Hypoparathyroidism‑sensorineural deafness‑renal disease syndrome. Dostupné z www:
  4. Joseph ADD, Sirisena ND, Kumanan T, Sujanitha V, Strelow V, Yamamoto R, Wieczorek S, Dissanayake VHW. Hypoparathyroidism, Sensorineural deafness and renal disease (Barakat syndrome) caused by a reduced gene dosage in GATA3: a case report and review of literature. BMC Endocr Disord. 2019 Oct 28;19(1):111. doi: 10.1186/s12902-019-0438-4. PMID: 31660939; PMCID: PMC6816161. Go to original source... Go to PubMed...
  5. Taslipinar A, Kebapcilar L, Kutlu M, Sahin M, Aydogdu A, Uckaya G, Azal O, Bolu E, Ibrahim Aydin H. HDR syndrome (hypoparathyroidism, sensorineural deafness and renal disease) accompanied by renal tubular acidosis and endocrine abnormalities. Intern Med. 2008;47(11):1003-7. doi: 10.2169/internalmedicine.47.0917. Epub 2008 Jun 2. PMID: 18520110. Go to original source... Go to PubMed...
  6. Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet. 2001 Jun;38(6):374-80. doi: 10.1136/jmg.38. 6. 374. PMID: 11389161; PMCID: PMC1734904. Go to original source... Go to PubMed...
  7. Hasegawa T, Hasegawa Y, Aso T, Koto S, Nagai T, Tsuchiya Y, Kim KC, Ohashi H, Wakui K, Fukushima Y. HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13). Am J Med Genet. 1997 Dec 31;73(4):416-8. doi: 10.1002/(sici)1096-8628(19971231)73:43. 0. co;2-l. PMID: 9415468. Go to original source... Go to PubMed...
  8. Fujimoto S, Yokochi K, Morikawa H, Nakano M, Shibata H, Togari H, Wada Y. Recurrent cerebral infarctions and del(10)(p14p15.1) de novo in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome. Am J Med Genet. 1999 Oct 29;86(5):427-9. doi: 10.1002/(sici)1096-8628(19991029)86:53. 0. co;2-i. PMID: 10508983. Go to original source... Go to PubMed...
  9. Hasegawa T., Quoted in Online mendelian Inheritance in Man, Personal communication, John Hopkins University #146255, 1998
  10. Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, Dobbie A, Hampson G, Holdaway I, Levine MA, McWilliams R, Rigden S, Sampson J, Williams AJ, Thakker RV. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem. 2004 May 21;279(21):22624-34. doi: 10.1074/jbc.M401797200. Epub 2004 Feb 24. PMID: 14985365. Go to original source... Go to PubMed...
  11. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K. GATA3 haplo‑insufficiency causes human HDR syndrome. Nature. 2000 Jul 27;406(6794):419-22. doi: 10.1038/35019088. PMID: 10935639. Go to original source... Go to PubMed...
  12. Yumita S, Furukawa Y, Sohn HE, Unakami H, Miura R, Yoshinaga K. Familial idiopathic hypoparathyroidism and progressive sensorineural deafness. Tohoku J Exp Med. 1986 Feb;148(2):135-41. doi: 10.1620/tjem.148.135. PMID: 3961795. Go to original source... Go to PubMed...
  13. Watanabe T, Mochizuki H, Kohda N, Minamitani K, Minagawa M, Yasuda T, Niimi H. Autosomal dominant familial hypoparathyroidism and sensorineural deafness without renal dysplasia. Eur J Endocrinol. 1998 Dec;139(6):631-4. doi: 10.1530/eje.0.1390631. PMID: 9916869. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.